April 15th, 2025 |
Karen Akinsanya |
President Of R&D, Therapeutics |
Exercise Sale
|
50.17K |
$525.26K |
32.35K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
3345 |
$2.92 |
$9.77K |
Common Stock |
Exercise/Conversion
|
13378 |
$3.22 |
$43.08K |
Common Stock |
Sale
|
8378 |
$25.11 |
$210.39K |
Common Stock |
Sale
|
5000 |
$25.11 |
$125.55K |
Common Stock |
Sale
|
3345 |
$25.00 |
$83.62K |
Stock Option (right to buy) |
Exercise/Conversion
|
13378 |
$3.22 |
$43.08K |
Stock Option (right to buy) |
Exercise/Conversion
|
3345 |
$2.92 |
$9.77K |
|
March 10th, 2025 |
Kralingen Van |
Director |
Stock Award
|
27.05K |
$358.39K |
17.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
17050 |
$21.02 |
$358.39K |
Common Stock |
Stock Award
|
10000 |
$0.00 |
$- |
|
March 10th, 2025 |
Kralingen Van |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
March 7th, 2025 |
Jenny Herman |
SVP & Controller |
Sale
|
666 |
$14.06K |
27.35K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
666 |
$21.11 |
$14.06K |
|
March 4th, 2025 |
Geoffrey Porges |
EVP & CFO |
Stock Award Sale
|
82.84K |
$1.18M |
50.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
50000 |
$21.24 |
$1.06M |
Common Stock |
Stock Award
|
14850 |
$0.00 |
$- |
Common Stock |
Sale
|
5491 |
$21.76 |
$119.48K |
Common Stock |
Stock Award
|
12500 |
$0.00 |
$- |
|
March 4th, 2025 |
Karen Akinsanya |
President Of R&D, Therapeutics |
Stock Award
|
78.12K |
$1.33M |
62.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
62500 |
$21.24 |
$1.33M |
Common Stock |
Stock Award
|
15625 |
$0.00 |
$- |
|
March 4th, 2025 |
Ramy Farid |
Director, Officer: President & CEO |
Stock Award
|
187.50K |
$3.38M |
221.93K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
37500 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
90000 |
$23.36 |
$2.10M |
Stock Option (right to buy) |
Stock Award
|
60000 |
$21.24 |
$1.27M |
|
March 4th, 2025 |
Margaret Dugan |
Chief Medical Officer |
Stock Award
|
62.50K |
$1.06M |
50.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
50000 |
$21.24 |
$1.06M |
Common Stock |
Stock Award
|
12500 |
$0.00 |
$- |
|
March 4th, 2025 |
Jenny Herman |
SVP & Controller |
Stock Award
|
18.20K |
$178.42K |
28.02K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
9800 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8400 |
$21.24 |
$178.42K |
|
March 4th, 2025 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Stock Award
|
62.50K |
$1.06M |
53.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
12500 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
50000 |
$21.24 |
$1.06M |
|
March 4th, 2025 |
Yvonne Tran |
Evp, Clo & Cpo |
Stock Award
|
62.50K |
$1.06M |
50.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
50000 |
$21.24 |
$1.06M |
Common Stock |
Stock Award
|
12500 |
$0.00 |
$- |
|
March 4th, 2025 |
Robert Abel |
See Remarks |
Stock Award
|
62.50K |
$1.06M |
50.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
50000 |
$21.24 |
$1.06M |
Common Stock |
Stock Award
|
12500 |
$0.00 |
$- |
|
February 19th, 2025 |
Yvonne Tran |
Evp, Clo & Cpo |
Exercise Sale
|
11.71K |
$143.13K |
15.04K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
3902 |
$4.34 |
$16.93K |
Common Stock |
Sale
|
3902 |
$28.00 |
$109.26K |
Stock Option (right to buy) |
Exercise/Conversion
|
3902 |
$4.34 |
$16.93K |
|
February 12th, 2025 |
Robert Abel |
See Remarks |
Sale
|
1.23K |
$31.84K |
8.12K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1225 |
$25.99 |
$31.84K |
|
February 12th, 2025 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Sale
|
985 |
$24.06K |
41.08K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
985 |
$24.43 |
$24.06K |
|
February 12th, 2025 |
Jenny Herman |
SVP & Controller |
Sale
|
859 |
$20.99K |
18.21K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
859 |
$24.43 |
$20.99K |
|
February 12th, 2025 |
Yvonne Tran |
Evp, Clo & Cpo |
Sale
|
828 |
$20.23K |
11.13K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
828 |
$24.43 |
$20.23K |
|
October 16th, 2024 |
Margaret Dugan |
Chief Medical Officer |
Sale
|
1.53K |
$27.23K |
13.47K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1531 |
$17.78 |
$27.23K |
|
June 20th, 2024 |
Jeffrey Chodakewitz |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Rosana Kapeller-libermann |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Michael Lynton |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Arun Oberoi |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Gary Sender |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Nancy Thornberry |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Richard Friesner |
Director |
Stock Award
|
13.55K |
$165.19K |
515.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
June 20th, 2024 |
Gary Ginsberg |
Director |
Stock Award
|
13.55K |
$165.19K |
11.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5000 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
8550 |
$19.32 |
$165.19K |
|
March 22nd, 2024 |
Robert Abel |
See Remarks |
Stock Award
|
30.00K |
$825.30K |
30.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
30000 |
$27.51 |
$825.30K |
|
March 22nd, 2024 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Stock Award
|
30.00K |
$825.30K |
30.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
30000 |
$27.51 |
$825.30K |
|
March 7th, 2024 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Exercise
|
11.15K |
$48.38K |
42.06K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5574 |
$4.34 |
$24.19K |
Stock Option (right to buy) |
Exercise/Conversion
|
5574 |
$4.34 |
$24.19K |
|
March 5th, 2024 |
Geoffrey Porges |
EVP & CFO |
Stock Award Sale
|
102.31K |
$2.36M |
90.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
90000 |
$25.24 |
$2.27M |
Common Stock |
Stock Award
|
9000 |
$0.00 |
$- |
Common Stock |
Sale
|
3315 |
$26.35 |
$87.36K |
|
March 5th, 2024 |
Ramy Farid |
Director, Officer: President & CEO |
Stock Award
|
213.27K |
$5.60M |
126.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
126000 |
$25.24 |
$3.18M |
Stock Option (right to buy) |
Stock Award
|
87271 |
$27.76 |
$2.42M |
|
March 5th, 2024 |
Jenny Herman |
SVP & Controller |
Stock Award
|
21.94K |
$369.13K |
19.07K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
7313 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
14625 |
$25.24 |
$369.13K |
|
March 5th, 2024 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Stock Award
|
60.00K |
$1.51M |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
60000 |
$25.24 |
$1.51M |
|
March 5th, 2024 |
Karen Akinsanya |
President Of R&D, Therapeutics |
Stock Award
|
120.00K |
$3.03M |
120.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
120000 |
$25.24 |
$3.03M |
|
March 5th, 2024 |
Yvonne Tran |
Evp, Clo & Cpo |
Stock Award
|
60.00K |
$1.51M |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
60000 |
$25.24 |
$1.51M |
|
March 5th, 2024 |
Margaret Dugan |
Chief Medical Officer |
Stock Award
|
60.00K |
$1.51M |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
60000 |
$25.24 |
$1.51M |
|
March 5th, 2024 |
Robert Abel |
See Remarks |
Stock Award
|
60.00K |
$1.51M |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
60000 |
$25.24 |
$1.51M |
|
February 13th, 2024 |
Yvonne Tran |
Evp, Clo & Cpo |
Sale
|
758 |
$21.44K |
11.96K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
758 |
$28.29 |
$21.44K |
|
February 13th, 2024 |
Robert Abel |
See Remarks |
Sale
|
1.21K |
$33.20K |
9.34K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
1205 |
$27.55 |
$33.20K |
|
February 13th, 2024 |
Jenny Herman |
SVP & Controller |
Sale
|
787 |
$22.26K |
11.76K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
787 |
$28.29 |
$22.26K |
|
February 13th, 2024 |
Kenneth Lorton |
Evp, CTO & Coo, Software |
Sale
|
901 |
$25.49K |
36.49K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
901 |
$28.29 |
$25.49K |
|
September 18th, 2023 |
Jenny Herman |
SVP & Controller |
Exercise
|
9.09K |
$10.91K |
12.55K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4545 |
$1.20 |
$5.45K |
Stock Option (right to buy) |
Exercise/Conversion
|
4545 |
$1.20 |
$5.45K |
|
August 10th, 2023 |
Margaret Dugan |
Chief Medical Officer |
Stock Award
|
105.00K |
$3.59M |
90.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
90000 |
$39.89 |
$3.59M |
Common Stock |
Stock Award
|
15000 |
$0.00 |
$- |
|
August 10th, 2023 |
Kenneth Lorton |
EVP & Chief Technology Officer |
Sale
|
10.00K |
$400.64K |
37.39K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10000 |
$40.06 |
$400.64K |
|
August 3rd, 2023 |
Margaret Dugan |
Officer |
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
July 3rd, 2023 |
Yvonne Tran |
Evp, Clo & Cpo |
Exercise Sale
|
36.12K |
$1.01M |
188.62K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
12040 |
$17.00 |
$204.68K |
Common Stock |
Exercise/Conversion
|
12040 |
$17.00 |
$204.68K |
Common Stock |
Sale
|
12040 |
$50.00 |
$602.00K |
|
June 16th, 2023 |
Nancy Thornberry |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Jeffrey Chodakewitz |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Rosana Kapeller-libermann |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Gary Ginsberg |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Richard Friesner |
Director |
Stock Award
|
18.75K |
$565.75K |
510.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
|
June 16th, 2023 |
Gary Sender |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Arun Oberoi |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
June 16th, 2023 |
Michael Lynton |
Director |
Stock Award
|
18.75K |
$565.75K |
12.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
12500 |
$45.26 |
$565.75K |
Common Stock |
Stock Award
|
6250 |
$0.00 |
$- |
|
May 24th, 2023 |
Yvonne Tran |
Evp, Clo & Cpo |
Exercise
|
14.89K |
$64.63K |
27.72K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
14892 |
$4.34 |
$64.63K |
|